News Focus
News Focus
icon url

JoJos Rabbit

04/24/20 7:39 AM

#226 RE: CLaSalle #224

That's exactly what I'm talking about.
Shareholders are looking for strong management here, to bring this stock to the next level.
One point worth examining further is the issue of dissent in management. Plowing through all the court documents regarding WMB and ETE, there are some really deep signs of problems. Specifically, documents show that board members have actually spoken against CEO Armstrong and expressed concerns about some very strange actions he took regarding the cancellation of the merger with ETE. Board members called Armstrong's actions “unbecoming of an officer of a public corporation.”
I couldn't find filings on the actual legal cost of this fight, but no doubt it is highly expensive. And the judge has indicated multiple times that WMB is not positioned to win this thing.
I would like to see more leadership from the CEO here. Ultimately, shareholders have to hold management accountable and I don't think they are acting in the best interest of the company. Likewise with the poison pill. It goes beyond protecting the company to being overly reactionary.
icon url

velcro

12/29/24 1:24 PM

#228 RE: CLaSalle #224

I suppose it somewhat depends on existing R/W securements on each side of the Energy Transfer crossing. It could be judged as a national security matter and ET must then negotiate in good faith. From ET's perspective, every month or year that the WMB crossing can be delayed is more profit for Energy Transfer.